ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,393Medicare Part D Prescriptions Filled, Including Refills

Rank: 265 out of 1844

$592K Total Retail Price of All Prescriptions

Rank: 238 out of 1844

290 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 290 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 5,954 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 318 193 S3 1 2
FUROSEMIDE 291 245 2 7
WARFARIN SODIUM 285 229 3 13
AMLODIPINE BESYLATE 217 184 4 6
LISINOPRIL 204 131 5 4
SIMVASTATIN 204 133 5 3
METFORMIN HCL 199 135 7 8
CIPROFLOXACIN HCL 187 123 8 62
NEXIUM 182 78 9 31
LEVOTHYROXINE SODIUM 178 105 10 1
OMEPRAZOLE 168 93 11 5
MELOXICAM 138 110 12 28
AZITHROMYCIN 137 78 13 37
GABAPENTIN 134 72 14 15
METOPROLOL SUCCINATE 130 79 15 14
CITALOPRAM HBR 120 105 16 19
METOPROLOL TARTRATE 120 101 16 11
ATENOLOL 118 67 18 17
TAMSULOSIN HCL 112 70 19 27
GLIMEPIRIDE 106 60 20 35
POTASSIUM CHLORIDE 106 104 20 16
PANTOPRAZOLE SODIUM 104 76 22 32
TRAMADOL HCL 97 57 23 18
MIRTAZAPINE 86 78 24 49
ATORVASTATIN CALCIUM 82 49 25 12
CYCLOBENZAPRINE HCL 80 38 R 26 53
DONEPEZIL HCL 77 77 27 26
SERTRALINE HCL 76 59 28 21
LOVAZA 75 14 29 138
LANTUS 73 42 30 42
ESCITALOPRAM OXALATE 70 33 31 52
NYSTATIN 67 63 32 85
CYMBALTA 67 26 32 36
ALLOPURINOL 64 53 34 29
INSULIN SYRINGE 64 47 34 111
ADVAIR DISKUS 63 47 36 51
POLYETHYLENE GLYCOL 3350 62 46 37 39
HYDROXYZINE HCL 62 33 R 37 164
FENTANYL 59 18 S2 39 66
VENLAFAXINE HCL ER 58 0 40 93
ZOLPIDEM TARTRATE 57 20 41 23
RISPERIDONE 57 42 41 65
FLUTICASONE PROPIONATE 56 29 43 50
IBUPROFEN 56 0 43 89
MORPHINE SULFATE ER 54 24 S2 45 107
CLOPIDOGREL 53 43 46 34
FAMOTIDINE 52 27 47 63
LOVASTATIN 51 23 48 44
NOVOLOG 51 46 48 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.